USPTO serial 79367019
SELECTRAP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRIEDMAN, LESLEE ANN
- Law office
- TMO LAW OFFICE 120
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SELECTRAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Immunostimulants; pharmaceutical preparations for treating malignant tumors; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes, namely, the treatment of cancer and biological preparations containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; polyclonal antibodies for medical purposes; pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and pharmaceuticals containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; tumor suppressing agents; monoclonal antibodies for medical purposes; bispecific antibodies for the treatment of medical conditions; bispecific antibodies for medical purposes; antibody pharmaceuticals for treating cancer; antibody diagnostic reagents for medicinal use; antibody diagnostic reagents for medical purposes; antibody reagents for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 24, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 24, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 11, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 7, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 20, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 4, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 4, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 5, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 15, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 15, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 12, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |